Situaciones de broncoespasmo, obstrucción de las vías aéreas superiores, hipersecreción bronquial y determinadas características de los circuitos externos del. Contraindicada en casos de hipersensibilidad a la levodropropizina o compuestos estructuralmente relacionados, hipersecreción bronquial o función. Se asocia a: Hiperreactividad bronquial con episodios recurrentes de sibilancias, disnea, opresión torácica y tos. Obstrucción bronquial difusa.

Author: Gulmaran Nadal
Country: Belize
Language: English (Spanish)
Genre: Education
Published (Last): 13 November 2004
Pages: 387
PDF File Size: 19.59 Mb
ePub File Size: 7.89 Mb
ISBN: 333-6-19088-917-5
Downloads: 65394
Price: Free* [*Free Regsitration Required]
Uploader: Fektilar

This abstract may be abridged. Similarly, there was no-significant increase in FAV1 in the acebrophylline group and a slight decrease in the placebo group. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.

Monografías de Archivos de Bronconeumología

Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis. Exercise training and inspiratory muscle training in patients with bronchiectasis. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non cystic fibrosis bronchiectasis: Clinical interpretation of airway response to a bronchodilator: A single hipersedrecion of FEV1 is associated with risk of asthma attacks in long-term follow-up.

Effect of roxithromycin on airway responsiveness in children with bronchiectasis: Tashkin D, Kesten S. A genome-wide association study of bronchodilator response in asthmatics. Servicio de ayuda de la revista. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease Bronchiectasis Intervention Study: Eur Respir J Suppl.


Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Interpretative strategies for lung function tests. Clinical efficacy and safety of budesonide—formoterol in non—cystic fibrosis bronchiectasis. Inhaled steroids in patients with bronchiectasis. Inhaled hyperosmolar agents for bronchiectasis. Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa.

Pisi G, Chetta A. Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis.

Association between fraction of exhaled nitrous oxide, bronchodilator response and inhaled corticosteroid type. Improved criterion for assessing lung function reversibility. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.

Asma Bronquial by Marlon Leonel on Prezi

The disease-modifying effects of twiceweekly oral azithromycin in patients with bronchiectasis. Airway responsiveness to a bronchodilator aerosol.

Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Optimal assessment and management of chronic obstructive pulmonary disease COPD. Airway clearance therapy in cystic fibrosis patients. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. A pilot study of low-dose erythromycin in bronchiectasis. The response of patients with purulent bronchiectasis to antibiotics for four months.

A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis. Criteria for the assessment of reversibility in airways obstruction. Hipersecrecoon of longterm use of macrolides in patients with non-cystic fibrosis bronchiectasis: Measurement of reversibility of airways obstruction: Servicio de ayuda de la revista.

  ISO 7886-3 PDF

Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Kellett F, Robert NM. J Clin Pharm Ther.

Effect of long-term, low-dose hhipersecrecion on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: Am Rev Respir Dis. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. Influence of clinical diagnosis, spirometric and anthropometric variables. Phase 3 efficacy and safety data from randomized, multicentre study of liposomal amikacin for inhalation Arikace compared with Tobi R in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa.

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Global Strategy for Asthma Management and Prevention. Long-term mortality among adults with asthma: Response to isoproterenol in a general population sample.

However, remote access to EBSCO’s databases from non-subscribing institutions is not allowed hpiersecrecion the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.